{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:52:05Z","timestamp":1787701925262,"version":"build-2784847793"},"reference-count":36,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.3892\/or.2013.2225","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T10:29:01Z","timestamp":1357295341000},"page":"932-940","source":"Crossref","is-referenced-by-count":9,"title":["Podoplanin overexpression in human mesothelioma cell lines enhances the tumorigenic phenotype"],"prefix":"10.3892","volume":"29","author":[{"given":"EI","family":"YAMAKI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TOSHIKI","family":"YAJIMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAKAYUKI","family":"KOSAKA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AKIRA","family":"MOGI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHIGEBUMI","family":"TANAKA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROYUKI","family":"KUWANO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,1,4]]},"reference":[{"key":"key20180107213931_b1-or-29-03-0932","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ncponc1039","article-title":"Advances in the systemic therapy of malignant pleural mesothelioma","volume":"5","author":"Fennell","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"key20180107213931_b2-or-29-03-0932","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjc.6603518","article-title":"The potential role of podoplanin in tumour invasion","volume":"96","author":"Wicki","year":"2007","journal-title":"Br J Cancer"},{"key":"key20180107213931_b3-or-29-03-0932","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0012-1606(02)00098-2","article-title":"T1alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth","volume":"256","author":"Ramirez","year":"2003","journal-title":"Dev Biol"},{"key":"key20180107213931_b4-or-29-03-0932","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1093\/emboj\/cdg342","article-title":"T1alpha\/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema","volume":"22","author":"Schacht","year":"2003","journal-title":"EMBO J"},{"key":"key20180107213931_b5-or-29-03-0932","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0002-9440(10)65285-6","article-title":"Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium","volume":"154","author":"Breiteneder-Geleff","year":"1999","journal-title":"Am J Pathol"},{"key":"key20180107213931_b6-or-29-03-0932","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000086952","article-title":"Enhanced expression of Aggrus (T1alpha\/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma","volume":"26","author":"Kato","year":"2005","journal-title":"Tumour Biol"},{"key":"key20180107213931_b7-or-29-03-0932","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/ijc.20656","article-title":"Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas","volume":"113","author":"Martin-Villar","year":"2005","journal-title":"Int J Cancer"},{"key":"key20180107213931_b8-or-29-03-0932","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0002-9440(10)62311-5","article-title":"Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors","volume":"166","author":"Schacht","year":"2005","journal-title":"Am J Pathol"},{"key":"key20180107213931_b9-or-29-03-0932","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00428-005-0133-x","article-title":"Podoplanin is expressed in subsets of tumors of the central nervous system","volume":"448","author":"Shibahara","year":"2006","journal-title":"Virchows Arch"},{"key":"key20180107213931_b10-or-29-03-0932","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ccr.2006.03.010","article-title":"Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton","volume":"9","author":"Wicki","year":"2006","journal-title":"Cancer Cell"},{"key":"key20180107213931_b11-or-29-03-0932","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1440-1827.2005.01791.x","article-title":"Podoplanin as a marker for mesothelioma","volume":"55","author":"Kimura","year":"2005","journal-title":"Pathol Int"},{"key":"key20180107213931_b12-or-29-03-0932","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.pap.0000213007.48479.94","article-title":"Podoplanin: a novel diagnostic immunohistochemical marker","volume":"13","author":"Ordonez","year":"2006","journal-title":"Adv Anat Pathol"},{"key":"key20180107213931_b13-or-29-03-0932","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/modpathol.3800736","article-title":"D2-40 and calretinin - a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation","volume":"20","author":"Hinterberger","year":"2007","journal-title":"Mod Pathol"},{"key":"key20180107213931_b14-or-29-03-0932","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/PAS.0b013e31814faacf","article-title":"Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin","volume":"32","author":"Padgett","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"key20180107213931_b15-or-29-03-0932","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/cncr.22477","article-title":"Novel marker D2-40, combined with calretinin, CEA, and TTF-1: an optimal set of immunodiagnostic markers for pleural mesothelioma","volume":"109","author":"Mimura","year":"2007","journal-title":"Cancer"},{"key":"key20180107213931_b16-or-29-03-0932","doi-asserted-by":"crossref","first-page":"397","DOI":"10.5858\/2008-132-397-AOITTD","article-title":"Application of immunohistochemistry to the diagnosis of malignant mesothelioma","volume":"132","author":"Marchevsky","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"key20180107213931_b17-or-29-03-0932","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1200\/JCO.2007.13.4072","article-title":"Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy","volume":"26","author":"Kawaguchi","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107213931_b18-or-29-03-0932","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.urology.2007.11.076","article-title":"Intratumoral lymphatics and lymphatic invasion are associated with tumor aggressiveness and poor prognosis in renal cell carcinoma","volume":"71","author":"Horiguchi","year":"2008","journal-title":"Urology"},{"key":"key20180107213931_b19-or-29-03-0932","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00401-006-0063-y","article-title":"Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression","volume":"111","author":"Mishima","year":"2006","journal-title":"Acta Neuropathol"},{"key":"key20180107213931_b20-or-29-03-0932","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1242\/jcs.03218","article-title":"Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition","volume":"119","author":"Martin-Villar","year":"2006","journal-title":"J Cell Sci"},{"key":"key20180107213931_b21-or-29-03-0932","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2353\/ajpath.2007.060790","article-title":"The platelet aggregation-inducing factor aggrus\/podoplanin promotes pulmonary metastasis","volume":"170","author":"Kunita","year":"2007","journal-title":"Am J Pathol"},{"key":"key20180107213931_b22-or-29-03-0932","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1242\/jcs.01707","article-title":"Cdc42 downregulates MMP-1 expression by inhibiting the ERK1\/2 pathway","volume":"118","author":"Deroanne","year":"2005","journal-title":"J Cell Sci"},{"key":"key20180107213931_b23-or-29-03-0932","first-page":"144","article-title":"Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases","volume":"8","author":"Zeng","year":"2002","journal-title":"Clin Cancer Res"},{"key":"key20180107213931_b24-or-29-03-0932","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ijc.11436","article-title":"Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients","volume":"107","author":"Tutton","year":"2003","journal-title":"Int J Cancer"},{"key":"key20180107213931_b25-or-29-03-0932","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1023\/A:1006542301794","article-title":"Platelet-derived growth factor (PDGF) BB acts as a chemoattractant for human malignant mesothelioma cells via PDGF receptor beta-integrin alpha3beta1 interaction","volume":"16","author":"Klominek","year":"1998","journal-title":"Clin Exp Metastasis"},{"key":"key20180107213931_b26-or-29-03-0932","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.canlet.2006.10.024","article-title":"Imatinib mesylate inhibits proliferation and modulates cytokine expression of human cancer-associated stromal fibroblasts from colorectal metastases","volume":"250","author":"Mueller","year":"2007","journal-title":"Cancer Lett"},{"key":"key20180107213931_b27-or-29-03-0932","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ejca.2006.02.012","article-title":"RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo","volume":"42","author":"Faried","year":"2006","journal-title":"Eur J Cancer"},{"key":"key20180107213931_b28-or-29-03-0932","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1158\/1078-0432.CCR-06-1056","article-title":"Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma","volume":"12","author":"Spugnini","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180107213931_b29-or-29-03-0932","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jcp.20605","article-title":"ERK1\/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells","volume":"207","author":"Zhong","year":"2006","journal-title":"J Cell Physiol"},{"key":"key20180107213931_b30-or-29-03-0932","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ijc.2910330115","article-title":"Role of NK cells in the antimetastatic effect of anticoagulant drugs","volume":"33","author":"Gorelik","year":"1984","journal-title":"Int J Cancer"},{"key":"key20180107213931_b31-or-29-03-0932","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1242\/jcs.112.24.4601","article-title":"Identification of PA2.26 antigen as a novel cell-surface mucin-type glycoprotein that induces plasma membrane extensions and increased motility in keratinocytes","volume":"112","author":"Scholl","year":"1999","journal-title":"J Cell Sci"},{"key":"key20180107213931_b32-or-29-03-0932","doi-asserted-by":"crossref","first-page":"25993","DOI":"10.1074\/jbc.M702327200","article-title":"Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells","volume":"282","author":"Suzuki-Inoue","year":"2007","journal-title":"J Biol Chem"},{"key":"key20180107213931_b33-or-29-03-0932","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/sj.bjc.6600920","article-title":"Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura","volume":"88","author":"Edwards","year":"2003","journal-title":"Br J Cancer"},{"key":"key20180107213931_b34-or-29-03-0932","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1038\/sj.onc.1202568","article-title":"Modulation of life and death by the TNF receptor superfamily","volume":"17","author":"Baker","year":"1998","journal-title":"Oncogene"},{"key":"key20180107213931_b35-or-29-03-0932","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1038\/sj.onc.1207556","article-title":"Mitogen-activated protein kinases in apoptosis regulation","volume":"23","author":"Wada","year":"2004","journal-title":"Oncogene"},{"key":"key20180107213931_b36-or-29-03-0932","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ygyno.2006.08.040","article-title":"A high nuclear basal level of ERK2 phosphorylation contributes to the resistance of cisplatin-resistant human ovarian cancer cells","volume":"104","author":"Lee","year":"2007","journal-title":"Gynecol Oncol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2013.2225\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T07:30:09Z","timestamp":1644046209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2013.2225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,4]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,1,4]]},"published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.3892\/or.2013.2225"],"URL":"https:\/\/doi.org\/10.3892\/or.2013.2225","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,4]]}}}